| A review on the dietary flavonoid kaempferol J M Calderon-Montano, E Burgos-Morón, C Pérez-Guerrero, ... Mini reviews in medicinal chemistry 11 (4), 298-344, 2011 | 1539 | 2011 |
| Distribution and biological activities of the flavonoid luteolin M López-Lázaro Mini reviews in medicinal chemistry 9 (1), 31-59, 2009 | 1268 | 2009 |
| Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy M López-Lázaro Cancer letters 252 (1), 1-8, 2007 | 748 | 2007 |
| Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent M López‐Lázaro Molecular nutrition & food research 52 (S1), S103-S127, 2008 | 553 | 2008 |
| The dark side of curcumin E Burgos‐Morón, JM Calderón‐Montaño, J Salvador, A Robles, ... International journal of cancer 126 (7), 1771-1775, 2010 | 406 | 2010 |
| The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? M López-Lázaro Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2008 | 378 | 2008 |
| Flavonoids as anticancer agents: structure-activity relationship study M Lopez-Lazaro Current Medicinal Chemistry-Anti-Cancer Agents 2 (6), 691-714, 2002 | 373 | 2002 |
| Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients M López-Lázaro, N Pastor, SS Azrak, MJ Ayuso, CA Austin, F Cortés Journal of natural products 68 (11), 1642-1645, 2005 | 244 | 2005 |
| Cytotoxic effect of Plantago spp. on cancer cell lines M Galvez, C Martın-Cordero, M Lopez-Lazaro, F Cortes, MJ Ayuso Journal of ethnopharmacology 88 (2-3), 125-130, 2003 | 243 | 2003 |
| Pro-oxidant natural products as anticancer agents C Martin-Cordero, A Jose Leon-Gonzalez, J Manuel Calderon-Montano, ... Current drug targets 13 (8), 1006-1028, 2012 | 191 | 2012 |
| Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved M López-Lázaro Expert opinion on therapeutic targets 11 (8), 1043-1053, 2007 | 170 | 2007 |
| A new view of carcinogenesis and an alternative approach to cancer therapy M López-Lázaro Molecular medicine 16, 144-153, 2010 | 167 | 2010 |
| Curcumin as a DNA topoisomerase II poison C Martín-Cordero, M López-Lázaro, M Gálvez, M Jesús Ayuso Journal of enzyme inhibition and medicinal chemistry 18 (6), 505-509, 2003 | 149 | 2003 |
| Evaluating the cancer therapeutic potential of cardiac glycosides JM Calderón-Montaño, E Burgos-Morón, ML Orta, D Maldonado-Navas, ... BioMed research international 2014 (1), 794930, 2014 | 141 | 2014 |
| The stem cell division theory of cancer M López-Lázaro Critical Reviews in Oncology / Hematology 123 (3), 95-113, 2018 | 139 | 2018 |
| The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells M López-Lázaro, E Willmore, CA Austin Mutation Research/Genetic Toxicology and Environmental Mutagenesis 696 (1 …, 2010 | 127 | 2010 |
| HIF‐1: hypoxia‐inducible factor or dysoxia‐inducible factor? M López‐Lázaro The FASEB journal 20 (7), 828-832, 2006 | 108 | 2006 |
| The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2′-deoxycytidine lesions ML Orta, A Höglund, JM Calderón-Montaño, I Domínguez, ... Nucleic acids research 42 (14), 9108-9120, 2014 | 92 | 2014 |
| The coffee constituent chlorogenic acid induces cellular DNA damage and formation of topoisomerase I–and II–DNA complexes in cells E Burgos-Moron, JM Calderón-Montaño, ML Orta, N Pastor, ... Journal of agricultural and food chemistry 60 (30), 7384-7391, 2012 | 87 | 2012 |
| 5-Aza-2′-deoxycytidine causes replication lesions that require Fanconi anemia-dependent homologous recombination for repair ML Orta, JM Calderon-Montano, I Dominguez, N Pastor, E Burgos-Moron, ... Nucleic acids research 41 (11), 5827-5836, 2013 | 85 | 2013 |
